C-terminus phosphorylation at BRAFS732/CRAFS624 finely tunes dimerization and MAPK activity by modulating 14-3-3 association to allosterically affect BRAF homodimer and BC heterodimer activity (Fig. 7). The gene discussed is BRAF; the disease is breast cancer.